03/28/2024 12:21 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 11:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024 7:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024 7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 10:19 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2024 9:33 AM | ImmunoPrecise Antibodies (Subject) INGALLS & SNYDER LLC (Filed by)
| Form SC 13G | |
02/23/2024 4:26 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
|
02/23/2024 4:29 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024 2:12 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
01/10/2024 12:53 PM | Charmquark TWEE (Filed by) ImmunoPrecise Antibodies (Subject)
| Form SC 13G/A | |
01/10/2024 12:33 PM | Charmquark TWEE (Filed by) ImmunoPrecise Antibodies (Subject)
| Form SC 13G | |
12/14/2023 7:48 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023 7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023 7:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023 4:11 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023 3:53 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
12/06/2023 4:19 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023 6:57 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023 5:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023 7:31 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023 4:13 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023 7:50 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2023 7:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2023 7:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/20/2023 1:56 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023 10:56 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023 3:46 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023 7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2023 1:47 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023 7:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023 7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/08/2023 7:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023 7:14 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2023 3:38 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
08/09/2023 8:15 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2023 11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
07/14/2023 7:10 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023 3:32 PM | ImmunoPrecise Antibodies (Filer)
| Form 40-F Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d) | |
07/07/2023 2:22 PM | ImmunoPrecise Antibodies (Subject) INGALLS & SNYDER LLC (Filed by)
| Form SC 13D | |
07/07/2023 7:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 8:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
06/13/2023 6:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023 7:09 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |